Biodesy LLC

South San Francisco, CA · CIK 0001452815 · Biotech · Defunct

Biodesy Delta device: a Second Harmonic Generation (SHG) optical platform for real-time measurement of biomolecule conformational changes upon ligand binding, used as a screening assay to identify com

biodesy.com →
Grants
$986K
4 awards
Sector median: 1
Raised
$350K
1 Form D · Dec 2009
202 months since last filing
Contracts
—
No federal contracts on record
Patents
10
0 granted · 10 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$350,009
Federal grantDepartment of Health and Human Services · Phase I · SHG based screening assay for detecting effectors of brain localized GPCRs that can be used to probe mental illness related phenotypes$279,745
Federal grantDepartment of Health and Human Services · Phase I · High-throughput screening assay of GPCR drug candidates using second harmonic generation for direct detection of structural changes$222,813
Federal grantDepartment of Health and Human Services · Phase I · High-throughput screening assay of GPCR drug candidates using second harmonic generation for direct detection of structural changes$222,813
Federal grantDepartment of Health and Human Services · Phase I · SHG based screening assay for detecting effectors of brain localized GPCRs that can be used to probe mental illness related phenotypes$260,927
Federal grant · SBIR/STTRForm D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2362ECM Therapeutics, Inc.—$919K
2363ACRIGEN BIOSCIENCES, INC.—$775K
2364MARCH BIOSCIENCES INC—$22M
2365Biodesy LLC—$350K
2366Montara Therapeutics—$28M
2367VST BIO Corp—$29M
2368Propagenix Inc—$2.3M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Joshua SalafskyExecutive Officer

Patents

USPTO · 0 granted of 10
  • Methods Using A Nonlinear Optical Technique For Detection Of Interactions Involving A Conformational Changeapplication
  • Methods Using A Nonlinear Optical Technique For Detection Of Interactions Involving A Conformational Changeapplication
  • Method Using A Nonlinear Optical Technique for Detection of Interactions Involving A Conformational Changeapplication
  • Method Using A Nonlinear Optical Technique for Detection of Interactions Involving A Conformational Changeapplication
  • Method Using A Nonlinear Optical Technique for Detection of Interactions Involving A Conformational Changeapplication
  • Methods Using A Nonlinear Optical Technique For Detection Of Interactions Involving A Conformational Changeapplication
  • Methods For Detecting Allosteric Modulators Of Proteinapplication
  • Classification Of Kinase Inhibitors Using Nonlinear Optical Techniquesapplication
  • Methods For Identifying Modulators Of Ras Using Nonlinear Techniquesapplication
  • Method Of Screening Drug Candidates Targeting A Target Biomoleculeapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.